GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » We Can Medicines Co Ltd (ROCO:6929) » Definitions » ROA %

We Can Medicines Co (ROCO:6929) ROA % : 1.40% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is We Can Medicines Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. We Can Medicines Co's annualized Net Income for the quarter that ended in Mar. 2024 was NT$43 Mil. We Can Medicines Co's average Total Assets over the quarter that ended in Mar. 2024 was NT$3,084 Mil. Therefore, We Can Medicines Co's annualized ROA % for the quarter that ended in Mar. 2024 was 1.40%.

The historical rank and industry rank for We Can Medicines Co's ROA % or its related term are showing as below:

ROCO:6929' s ROA % Range Over the Past 10 Years
Min: 0.22   Med: 2.19   Max: 4.18
Current: 0.22

During the past 4 years, We Can Medicines Co's highest ROA % was 4.18%. The lowest was 0.22%. And the median was 2.19%.

ROCO:6929's ROA % is ranked worse than
70.36% of 1906 companies
in the Consumer Packaged Goods industry
Industry Median: 3.035 vs ROCO:6929: 0.22

We Can Medicines Co ROA % Historical Data

The historical data trend for We Can Medicines Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

We Can Medicines Co ROA % Chart

We Can Medicines Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROA %
2.42 1.95 4.18 0.54

We Can Medicines Co Quarterly Data
Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 3.00 -0.97 -0.59 0.83 1.40

Competitive Comparison of We Can Medicines Co's ROA %

For the Packaged Foods subindustry, We Can Medicines Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


We Can Medicines Co's ROA % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's ROA % distribution charts can be found below:

* The bar in red indicates where We Can Medicines Co's ROA % falls into.



We Can Medicines Co ROA % Calculation

We Can Medicines Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=14.803/( (2575.834+2860.853)/ 2 )
=14.803/2718.3435
=0.54 %

We Can Medicines Co's annualized ROA % for the quarter that ended in Mar. 2024 is calculated as:

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=43.228/( (2860.853+3306.239)/ 2 )
=43.228/3083.546
=1.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data. ROA % is displayed in the 30-year financial page.


We Can Medicines Co  (ROCO:6929) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=43.228/3083.546
=(Net Income / Revenue)*(Revenue / Total Assets)
=(43.228 / 3272.388)*(3272.388 / 3083.546)
=Net Margin %*Asset Turnover
=1.32 %*1.0612
=1.40 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


We Can Medicines Co ROA % Related Terms

Thank you for viewing the detailed overview of We Can Medicines Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


We Can Medicines Co (ROCO:6929) Business Description

Traded in Other Exchanges
N/A
Address
Section 4, Taiwan Avenue, 20th Floor-1, No. 925, Xitun District, Taichung, TWN
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.

We Can Medicines Co (ROCO:6929) Headlines

No Headlines